Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico

NCT02112890 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02112890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02112890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
December 10, 2014
Completion date
May 2, 2016
Enrollment
1,603 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis a, viral hepatitis vaccines